|本期目录/Table of Contents|

[1]白若靖,郭 军.维生素D对肺部疾病临床意义的研究进展[J].中华肺部疾病杂志,2024,(04):659-662.[doi:10.3877/cma.j.issn.1674-6902.2024.04.033 ]
点击复制

维生素D对肺部疾病临床意义的研究进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2024年04期
页码:
659-662
栏目:
综述
出版日期:
2024-08-25

文章信息/Info

Title:
-
作者:
白若靖; 郭 军
102218 北京,清华大学附属北京清华长庚医院清华大学临床医学院老年医学科
Author(s):
-
关键词:
支气管肺炎;  肺结核;  支气管哮喘;  肺疾病; 慢性阻塞性;  维生素D
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2024.04.033
摘要:
-
Abstract:
-

参考文献/References:

1 中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物的临床应用共识[J]. 中华内分泌代谢杂志, 2018, 34(3): 187-200.
2 Gibbons JB, Norton EC, McCullough JS, et al. Association between vitamin D supplementation and COVID-19 infection and mortality[J]. Sci Rep, 2022, 12(1): 19397.
3 Sassi F, Tamone C, D'Amelio P. Vitamin D: nutrient, hormone, and immunomodulator[J]. Nutrients, 2018, 10(11): E1656.
4 Verlinden L, Carmeliet G. Integrated view on the role of vitamin D actions on bone and growth plate homeostasis[J]. JBMR Plus, 2021, 5(12): e10577.
5 Nuwagira E, Stadelman A, Baluku JB, et al. Obstructive lung disease and quality of life after cure of multi-drug-resistant tuberculosis in Uganda: a cross-sectional study[J]. Trop Med Health, 2020, 48(1): 34.
6 Gayan-Ramirez G, Janssens W. Vitamin D actions: the lung is a major target for vitamin D, FGF23, and klotho[J]. JBMR Plus, 2021, 5(12): e10569.
7 Zhu M, Wang T, Wang C, et al. The association between vitamin D and COPD risk, severity, and exacerbation: An updated systematic review and meta-analysis[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2597-2607.
8 潘晓芳, 吴静标, 黄燕虹, 等. 我国25-羟基维生素D检测方法及其研究进展[J]. 分子诊断与治疗杂志, 2020, 12(12): 1591-1595.
9 张诗颜, 卓 影, 王庭强, 等. 维生素D和肠道菌群对结直肠癌的预防作用[J]. 中国卫生标准管理, 2023, 14(10): 189-193.
10 周晓春, 陈 晓. 维生素D与2型糖尿病关系的研究进展[J]. 中国全科医学, 2014, 17(14): 1577-1580.
11 邓杰忠, 杨宇生, 何晋月, 等. 1,25(OH)2D3通过抑制IκB/NF-κB信号通路抑制破骨细胞生成[J]. 第三军医大学学报, 2021, 43(14): 1339-1345.
12 Martens PJ, Gysemans C, Verstuyf A, et al. Vitamin D's effect on immune function[J]. Nutrients, 2020, 12(5): E1248.
13 Bishop EL, Ismailova A, Dimeloe S, et al. Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory[J]. JBMR Plus, 2021, 5(1): e10405.
14 郑羽旋, 魏 迅, 张乐文, 等. 维生素D与糖尿病关系的研究进展[J]. 中国糖尿病杂志, 2023, 31(6): 472-475.
15 赵文慧, 郭 伟. 维生素D作用与糖尿病关系的研究进展[J]. 生物过程, 2023, 13(3): 135-141.
16 Hansdottir S, Monick MM. Vitamin D effects on lung immunity and respiratory diseases[J]. Vitam Horm, 2011, 86: 217-237.
17 陈立君. 肺部感染的护理措施[J/CD]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(7): 111.
18 Bleakley AS, Licciardi PV, Binks MJ. Vitamin D modulation of the innate immune response to paediatric respiratory pathogens associated with acute lower respiratory infections[J]. Nutrients, 2021, 13(1): 276.
19 Ahmad S, Arora S, Khan S, et al. Vitamin D and its therapeutic relevance in pulmonary diseases[J]. J Nutr Biochem, 2021, 90: 108571.
20 Gupta P, Dewan P, Shah D, et al. Vitamin D supplementation for treatment and prevention of pneumonia in under-five children: a randomized double-blind placebo controlled trial[J]. Indian Pediatr, 2016, 53(11): 967-976.
21 Murdaca G, Pioggia G, Negrini S. Vitamin D and COVID-19: An update on evidence and potential therapeutic implications[J]. Clin Exp Allergy, 2020, 18(1): 23.
22 Ma D, Peng L. Vitamin D and pulmonary fibrosis: a review of molecular mechanisms[J]. Int J Clin Exp Pathol, 2019, 12(9): 3171-3178.
23 Bagcchi S. WHO's Global Tuberculosis Report 2022[J]. Lancet Microbe, 2023, 4(1): e20.
24 Aibana O, Huang C-C, Aboud S, et al. Vitamin D status and risk of incident tuberculosis disease: a nested case-control study, systematic review, and individual-participant data meta-analysis[J]. PLoS Med, 2019, 16(9): e1002907.
25 Soeharto DA, Rifai DA, Marsudidjadja S, et al. Vitamin D as an adjunctive treatment to standard drugs in pulmonary tuberculosis patients: an evidence-based case report[J]. Adv Prev Med, 2019, 2019: 5181847.
26 Papagni R, Pellegrino C, Di Gennaro F, et al. Impact of vitamin D in prophylaxis and treatment in tuberculosis patients[J]. Int J Mol Sci, 2022, 23(7): 3860.
27 Cai L, Wang G, Zhang P, et al. The progress of the prevention and treatment of Vitamin D to tuberculosis[J]. Front Nutr, 2022, 9: 873890.
28 Wang J, Feng M, Ying S, et al. Efficacy and safety of vitamin D supplementation for pulmonary tuberculosis: a systematic review and meta-analysis[J]. Iran J Public Health, 2018, 47(4): 466-472.
29 Jolliffe DA, Ganmaa D, Wejse C, et al. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data[J]. Eur Respir J, 2019, 53(3): 1802003.
30 Mily A, Rekha RS, Kamal SMM, et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial[J]. PLoS One, 2015, 10(9): e0138340.
31 Maes K, Serré J, Mathyssen C, et al. Targeting vitamin D deficiency to limit exacerbations in respiratory diseases: utopia or strategy with potential?[J]. Calcif Tissue Int, 2020, 106(1): 76-87.
32 Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide[J]. Eur J Clin Nutr, 2020, 74(11): 1498-1513.
33 Mims JW. Asthma: definitions and pathophysiology[J]. Int Forum Allergy Rhinol, 2015, 5(S1): S2-S6.
34 Martineau AR, Cates CJ, Urashima M, et al. Vitamin D for the management of asthma[J]. Cochrane Database Syst Rev, 2016, 9: CD011511.
35 Cherrie MPC, Sarran C, Osborne NJ. Association between serum 25-hydroxy vitamin D levels and the prevalence of adult-onset asthma[J]. Int J Environ Res Public Health, 2018, 15(6): E1103.
36 Liu M, Wang J, Sun X. A meta-analysis on vitamin D supplementation and asthma treatment[J]. Front Nutr, 2022, 9: 860628.
37 Liu J, Dong Y-Q, Yin J, et al. Meta-analysis of vitamin D and lung function in patients with asthma[J]. Respir Res, 2019, 20(1): 161.
38 Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data[J]. Lancet Respir Med, 2017, 5(11): 881-890.
39 Pfeffer PE. Targeting the exposome: does correcting vitamin D deficiency have potential to treat and prevent asthma?[J]. Expert Rev Clin Immunol, 2018, 14(4): 241-243.
40 Davidson BL, Alansari K. Vitamin D deficiency can impair respiratory health[J]. Respirology, 2018, 23(6): 554-555.
41 Wang M, Liu M, Wang C, et al. Association between vitamin D status and asthma control: a meta-analysis of randomized trials[J]. Respir Med, 2019, 150: 85-94.
42 Chen Z, Peng C, Mei J, et al. Vitamin D can safely reduce asthma exacerbations among corticosteroid-using children and adults with asthma: a systematic review and meta-analysis of randomized controlled trials[J]. Nutr Res, 2021, 92: 49-61.
43 Rafiq R, Thijs W, Prein R, et al. Associations of serum 25(OH)D concentrations with lung function, airway inflammation and common cold in the general population[J]. Nutrients, 2018, 10(1): E35.
44 Pfeffer PE, Hawrylowicz CM. Vitamin D in asthma: mechanisms of action and considerations for clinical trials[J]. Chest, 2018, 153(5): 1229-1239.
45 Hall SC, Agrawal DK. Vitamin D and bronchial asthma: an overview of data from the past 5 years[J]. Clin Ther, 2017, 39(5): 917-929.
46 Cho SW, Kim JH, Choi JH, et al. Preventive and therapeutic effects of vitamin D in a mouse model of allergic asthma[J]. Asian Pac J Allergy Immunol, 2019, 37(3): 130-137.
47 Souto Filho JTD, de Andrade AS, Ribeiro FM, et al. Impact of vitamin D deficiency on increased blood eosinophil counts[J]. Hematol Oncol Stem Cell Ther, 2018, 11(1): 25-29.
48 Szymczak-Pajor I, Kleniewska P, Wieczfinska J, et al. Wide-range effects of 1,25(OH)2D3 on group 4A phospholipases is related to nuclear factor κ-B and phospholipase-A2 activating protein activity in mast cells[J]. Int Arch Allergy Immunol, 2020, 181(1): 56-70.
49 Pfeffer PE, Lu H, Mann EH, et al. Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter[J]. PLoS One, 2018, 13(8): e0200040.
50 Sun D, Luo F, Xing JC, et al. 1,25(OH)2D3 inhibited Th17 cells differentiation via regulating the NF-κB activity and expression of IL-17[J]. Cell Prolif, 2018, 51(5): e12461.
51 Shabana MA, Esawy MM, Ismail NA, et al. Predictive role of IL-17A/IL-10 ratio in persistent asthmatic patients on vitamin D supplement[J]. Immunobiology, 2019, 224(6): 721-727.
52 Ma JG, Wu GJ, Xiao HL, et al. Vitamin D has an effect on airway inflammation and Th17/Treg balance in asthmatic mice[J]. Kaohsiung J Med Sci, 2021, 37(12): 1113-1121.
53 Williamson A, Martineau AR, Sheikh A, et al. Vitamin D for the management of asthma[J]. Cochrane Database Syst Rev, 2023, 2: CD011511.
54 Kumar J, Kumar P, Goyal JP, et al. Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials[J]. ERJ Open Res, 2022, 8(1): 662-2021.
55 慢性阻塞性肺疾病急性加重诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志, 2017, 37(14): 17.
56 Global Initiative for Chronic Obstructive Lung Disease(GOLD). Pocket guide to COPD diagnosis, management, and prevention: a guide for health care professionals[R]. Fontana: GOLD, Inc., 2023.

备注/Memo

备注/Memo:
基金项目: 清华大学精准医学科研计划(QT201901)
北京市卫生健康委员会高层次公共卫生技术人才建设项目培养计划(学科带头人-02-06)
通信作者: 郭 军, Email: junguo_med@tsinghua.edu.cn
更新日期/Last Update: 2024-08-25